559 related articles for article (PubMed ID: 11483727)
1. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
[TBL] [Abstract][Full Text] [Related]
2. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
[TBL] [Abstract][Full Text] [Related]
3. IE1-pp65 recombinant protein from human CMV combined with a nanoparticulate carrier, SMBV, as a potential source for the development of anti-human CMV adoptive immunotherapy.
Vaz-Santiago J; Lulé J; Rohrlich P; Kravtzoff R; Le Roy E; Davignon JL; Betbeder D; Davrinche C
Cytotherapy; 2002; 4(1):11-9. PubMed ID: 11953037
[TBL] [Abstract][Full Text] [Related]
4. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P
Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388
[TBL] [Abstract][Full Text] [Related]
5. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.
Gibson L; Piccinini G; Lilleri D; Revello MG; Wang Z; Markel S; Diamond DJ; Luzuriaga K
J Immunol; 2004 Feb; 172(4):2256-64. PubMed ID: 14764694
[TBL] [Abstract][Full Text] [Related]
6. Refinement in the production and purification of recombinant HCMV IE1-pp65 protein for the generation of epitope-specific T cell immunity.
Nguyen TH; Mifsud NA; Stewart LA; Rose MJ; Etto TL; Williamson NA; Purcell AW; Kotsimbos T; Schwarer AP
Protein Expr Purif; 2008 Sep; 61(1):22-30. PubMed ID: 18539483
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens.
Albiero E; Amati E; Baumeister E; Einsele H; Grigoleit GU; Rodeghiero F
J Immunother; 2016; 39(9):329-342. PubMed ID: 27631893
[TBL] [Abstract][Full Text] [Related]
8. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG
J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876
[TBL] [Abstract][Full Text] [Related]
9. Cross-presentation of HCMV chimeric protein enables generation and measurement of polyclonal T cells.
Nguyen TH; Sullivan LC; Kotsimbos TC; Schwarer AP; Mifsud NA
Immunol Cell Biol; 2010 Aug; 88(6):676-84. PubMed ID: 20195281
[TBL] [Abstract][Full Text] [Related]
10. Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation.
Paine A; Oelke M; Tischer S; Heuft HG; Blasczyk R; Eiz-Vesper B
J Immunother; 2010 Jan; 33(1):60-72. PubMed ID: 19952955
[TBL] [Abstract][Full Text] [Related]
11. Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response.
Retière C; Prod'homme V; Imbert-Marcille BM; Bonneville M; Vié H; Hallet MM
J Virol; 2000 May; 74(9):3948-52. PubMed ID: 10756006
[TBL] [Abstract][Full Text] [Related]
12. Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2.
Braendstrup P; Mortensen BK; Justesen S; Osterby T; Rasmussen M; Hansen AM; Christiansen CB; Hansen MB; Nielsen M; Vindeløv L; Buus S; Stryhn A
PLoS One; 2014; 9(4):e94892. PubMed ID: 24760079
[TBL] [Abstract][Full Text] [Related]
13. Influence of HIV infection on cytomegalovirus-specific immunity: T-cell responses to pp65 and IE1 before and after HAART may reflect altered cytomegalovirus biology.
Scherrenburg J; Schellens IM; van Baarle D
Antivir Ther; 2011; 16(4):565-75. PubMed ID: 21685544
[TBL] [Abstract][Full Text] [Related]
14. A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2- donors.
Foster AE; Bradstock KF; Sili U; Marangolo M; Rooney CM; Gottlieb DJ
Biol Blood Marrow Transplant; 2004 Nov; 10(11):761-71. PubMed ID: 15505607
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs.
Gyulai Z; Endresz V; Burian K; Pincus S; Toldy J; Cox WI; Meric C; Plotkin S; Gönczöl E; Berencsi K
J Infect Dis; 2000 May; 181(5):1537-46. PubMed ID: 10823751
[TBL] [Abstract][Full Text] [Related]
16. Rapid generation of CMV pp65-specific T cells for immunotherapy.
Bao L; Sun Q; Lucas KG
J Immunother; 2007; 30(5):557-61. PubMed ID: 17589296
[TBL] [Abstract][Full Text] [Related]
17. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
[TBL] [Abstract][Full Text] [Related]
18. An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.
Barabas S; Spindler T; Kiener R; Tonar C; Lugner T; Batzilla J; Bendfeldt H; Rascle A; Asbach B; Wagner R; Deml L
BMC Immunol; 2017 Mar; 18(1):14. PubMed ID: 28270111
[TBL] [Abstract][Full Text] [Related]
19. The matrix protein pp65(341-350): a peptide that induces ex vivo stimulation and in vitro expansion of CMV-specific CD8+ T cells in subjects bearing either HLA-A*2402 or A*0101 allele.
Provenzano M; Lim JB; Mocellin S; Monsurro V; Bettinotti M; Marincola FM; Stroncek DF
Transfusion; 2003 Nov; 43(11):1567-74. PubMed ID: 14617317
[TBL] [Abstract][Full Text] [Related]
20. Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.
Lilleri D; Zelini P; Fornara C; Comolli G; Revello MG; Gerna G
Clin Immunol; 2009 Jun; 131(3):395-403. PubMed ID: 19268633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
